This brand name is authorized in Cyprus, Estonia, France, Hong Kong, Lithuania, Poland, Romania, Singapore, Tunisia
The drug FORTRANS contains a combination of these active pharmaceutical ingredients (APIs):
|
1
Macrogol 4000
UNII 4R4HFI6D95 - POLYETHYLENE GLYCOL 4000
|
|
High molecular weight (4000) macrogols are long linear polymers which retain water molecules by means of hydrogen bonds. When administered by the oral route, they lead to an increase in volume of intestinal fluids. |
|
2
Sodium sulfate
UNII 36KCS0R750 - SODIUM SULFATE ANHYDROUS
|
|
Sodium Sulfate Anhydrous is the anhydrous, sodium salt form of sulfuric acid. Sodium sulfate anhydrous disassociates in water to provide sodium ions and sulfate ions. Sodium ion is the principal cation of the extracellular fluid and plays a large part in the therapy of fluid and electrolyte disturbances. Sodium sulfate anhydrous is an electrolyte replenisher and is used in isosmotic solutions so that administration does not disturb normal electrolyte balance and does not lead to absorption or excretion of water and ions. |
|
3
Sodium bicarbonate
UNII 8MDF5V39QO - SODIUM BICARBONATE
|
|
Sodium bicarbonate has antacid properties. Sodium bicarbonate causes neutralisation of gastric acid with the production of carbon dioxide. |
|
4
Sodium chloride
UNII 451W47IQ8X - SODIUM CHLORIDE
|
|
Sodium chloride is the principle salt involved in maintaining the osmotic tension of blood and tissues. Changes in osmotic tension influence the movement of fluids and diffusion of salts in cellular tissue. |
|
5
Potassium chloride
UNII 660YQ98I10 - POTASSIUM CHLORIDE
|
|
Potassium plays a vital physiological role in maintenance of normal electrical excitability of nerve and muscle. It is also important in the genesis and correction of imbalances of acid-base metabolism. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| A06AD65 | Macrogol, combinations | A Alimentary tract and metabolism → A06 Laxatives → A06A Laxatives → A06AD Osmotically acting laxatives |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: EE | Ravimiamet | Identifier(s): 1035346 |
| Country: FR | Base de données publique des médicaments | Identifier(s): 69559248 |
| Country: HK | Department of Health Drug Office | Identifier(s): 41626 |
| Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1015757, 1074490, 1075364 |
| Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100075325, 100265149, 100351587, 100352368, 100353296, 100365595, 100365945, 100366034, 100374915, 100383423, 100393500, 100415360, 100418854, 100419233, 100419530, 100441669, 100463536, 100465183 |
| Country: RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | Identifier(s): W66208001 |
| Country: SG | Health Sciences Authority | Identifier(s): 09234P |
| Country: TN | Direction de la Pharmacie et du Médicament | Identifier(s): 5133021 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
